RxDoctor Payments Data

Angela Hou

Dermatology · Arlington, VANPI 1841725769

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,081 of the $17,357 with a category attached, or 69.6%. It is spread thinly across 28 manufacturers, the largest accounting for just 19.4%. Among dermatology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,357in general payments, 2019–2025

Across 445 payments — averaging $39.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$3K
  • Dermavant Sciences, Inc.$3K
  • AbbVie$2K
  • Johnson & Johnson$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Incyte Corporation$1K
  • plus $6K from 22 others
$1,789in research payments, 2019–2025

Across 9 payments — averaging $198.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$2K

What the payments were for

  • Consulting fees$2,00012%
  • Speaking & faculty fees$2,70016%
  • Food & beverage$12,08170%
  • Education$5773%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,357 in reported general payments places this provider in the 90th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$258,884
Medicare patients
581
Services billed
2,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate35$1,847
Azelaic Acid15$1,278
Fluocinonide29$1,263
Doxycycline Hyclate22$927
Fluorouracil15$872
Ketoconazole57$829
Clindamycin Phosphate13$795
Metronidazole13$769
Ciclopirox26$763
Triamcinolone Acetonide44$354
Finasteride11$140
Hydrocortisone16$63

Paid to pharmacies, not to this prescriber.

Other dermatology in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →